BlossomHill Therapeutics
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- $244M
Investors
- 10
About BlossomHill Therapeutics
Founded in 2020 and based in California, US, BlossomHill Therapeutics, Inc. operates as a molecule drug discovery and development company. The company was co-founded by President and CEO Dr. J. Jean Cui and Dr. Y. Peter Li. In December 2025, BlossomHill Therapeutics, Inc. BlossomHill Therapeutics is a small molecule drug discovery and development company focused on unmet medical needs in oncology, identifying key clinical needs, and discovering autoimmune disorders.
Who invested in BlossomHill Therapeutics
10 investors across 3 rounds
See all investors in BlossomHill Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about BlossomHill Therapeutics
Who invested in BlossomHill Therapeutics?
BlossomHill Therapeutics has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BlossomHill Therapeutics raised?
BlossomHill Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did BlossomHill Therapeutics last raise money?
BlossomHill Therapeutics's most recent round on record is a Series B, in Nov 2025.
What does BlossomHill Therapeutics do?
Founded in 2020 and based in California, US, BlossomHill Therapeutics, Inc.
Where is BlossomHill Therapeutics headquartered?
BlossomHill Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like BlossomHill Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BlossomHill Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like BlossomHill Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.